Navigation Links


ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results

7/10/2014
SAN DIEGO , July 10, 2014  RESMED INC. (NYSE: RMD ) today announced that it will report its fourth quarter and fiscal year ended June 30, 2014 results on Thursday, July 31, 2014, after the New York Stock Exchange market close. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating resu... [Comments]

Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care

7/10/2014
AMBLER, Pa. , July 10, 2014 Yesterday, former Congressman Patrick Kennedy visited Moberg Research's (Moberg) medical device manufacturing facility. Rep. Kennedy and Dick Moberg discussed how Moberg's advanced neurological monitors facilitate cutting-edge research in neurological disease and treatment. In 2011, Rep. Kennedy and mental health advocate, Garen Staglin , cre... [Comments]

BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service

7/10/2014
WEST JORDAN, Utah , July 10, 2014  BC Technical, the largest nationwide, non-OEM provider of medical imaging solutions, and MiE America , Inc., a leading provider of Siemens Nuclear Medicine and Molecular Imaging systems, have entered into a long-term agreement naming BC Technical as the authorized provider of service and systems in the US. MiE and BC Technical announc... [Comments]

Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma

7/10/2014
LAVAL, Quebec , July 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the sale to Galderma of all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 billion in cash, pursuant to the previously announced agreement with Nestle S.A, which recently completed its acquis... [Comments]

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment

7/10/2014
TUCSON, Ariz. , July 10, 2014   Ventana Medical Systems, Inc.  (Ventana), a member of the  Roche  Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany , which operates as EMD Serono in the United States and Canada , to collaborate with Merck KGaA's biopharmaceutical division on the development and commercializ... [Comments]

Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)

7/10/2014
BURLINGTON, Mass. , July 10, 2014  Decision Resources Group finds that while more than three-quarters of surveyed infectious disease (ID) specialists are willing to prescribe Durata's Dalvance (dalbavancin) and The Medicines Company's Orbactiv (oritavancin) for use as OPAT, approximately two-thirds of the respondents reported a willingness to prescribe these agents to thei... [Comments]

LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors

7/10/2014
CAESAREA, Israel , July 10, 2014   LabStyle Innovations Corp . (OTCQB:DRIO), developer of the Dario™ Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors. Prof. Stone brings over forty-five years of legal and business experience to LabStyle as an entrepreneur, venture c... [Comments]

CVS Caremark Corporation Announces Quarterly Dividend

7/10/2014
WOONSOCKET, R.I. , July 10, 2014 CVS Caremark Corporation (NYSE: CVS ) today announced that its board of directors has approved a quarterly dividend of $0.275 (27.5 cents) per share on the corporation's common stock. The dividend is payable on August 1, 2014, to holders of record on July 21, 2014. About CVS Caremark CVS Caremark is dedicated to helping people on their p... [Comments]

Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis

7/10/2014
BURLINGTON, Mass. , July 10, 2014 Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of hyperphosphatemia in chronic kidney disease (CKD) pa... [Comments]

Sono-Tek Announces Third Quarter Results

1/15/2014
MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  $2,650,000 for the three months ended November 30, 2013, compared to sales of $2,202,000 for the prior year period, an increase of $448,000 or 20%. Once again, this quarter has also shown growth over the preceding quarter,s sales, continuing a trend that began in the first quarter of this fiscal year.... [Comments]

[previous] [next]
(Date:7/11/2014)... New York, NY (PRWEB) July 11, 2014 ... ( http://www.gynecaremorcellatorlawsuit.com/ ) investigation, Bernstein Liebhard LLP has ... U.S. Food & Drug Administration’s (FDA) Obstetrics ... to explore ways to mitigate the cancer risks ... minimally invasive gynecological surgeries. According to a report ...
(Date:7/11/2014)... Datalogic brings a new and innovative scanner ... With their new Gryphon GD4400 and GM4400 ... devastating MRSA, which claimed 5,500 lives, becomes more preventable. ... and the Gryphon GM4400-HC 2D readers can scan nearly ... barcodes off of troublesome LCD monitors, smartphones, and other ...
(Date:7/11/2014)... -- In people with sex addiction, pornography affects the ... in drug addicts as they consume drugs, a new ... activity between patients who have compulsive sexual behavior and ... study author Dr. Valerie Voon, of the University of ... Voon,s research involved 19 men with sex addiction ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap ... comes to the summer concert schedule, it just isn’t complete without ... of the biggest names in country music and one of the ... his “That’s My Kind of Night” tour featuring Lee Brice and ... through the rest of the summer and into the fall includes ...
(Date:7/11/2014)... July 11, 2014 According to a ... Application Market by Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, ... Industrial, Automotive & Transportation, Agriculture) & Geography - Global ... of Internet of Things market was worth $1029.5 Billion ... by 2020, at an estimated CAGR of 4.08% from ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4
... physicians taking part in the Physicians' Health Study, those ... cereals reduced their risk of heart failure by 22 ... at the American Heart Association's 47th Annual Conference on ... strong body of evidence linking the consumption of wholegrain ...
... It's already been established that type 2 diabetes increases the ... also a link between type 1 diabetes and this type ... but still, those with type 1 diabetes have a likelihood ... in non-diabetics. This is similar to the risk those with ...
... panic disorder and other mental health conditions are potentially around ... study. ,The findings, which were based on analysis ... March 6 in the American Journal of Medical Genetics. ... a quantum leap in psychiatry,' said the study's lead author, ...
... has said that India, home to 12 million blind people, ... 2015, five years before the World Health Organisation (WHO) deadline ... a little above 1.1 percent. And looking at the progress ... We are quite sure that the WHO target of 0.3 ...
... team led by a University of Leicester geologist was recently ... to detect exposure of UK troops to depleted uranium (DU) ... ,Randall Parrish, Professor of Isotope Geology, developed the test with ... University of Frankfurt, Germany, and his colleague Matt Horstwood at ...
... Studying the genetic make-up using blood samples to detect ... been in practice//. Now, scientists have gone a bit ... tests that might reveal the latent tendencies in people ... personality disorder. ,Such tests would not dictate ...
Cached Medicine News:Health News:Whole Grain Breakfasts Linked to Lower Heart Failure Risk 2Health News:Blood Tests may Be Possible for Mental Health Conditions 2Health News:DU Test Finds UK Troops Uranium Free 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 3
Curved shafts with micro Pierse type tips. Flat open serrated handle with dull finish....
Straight shafts with 0.1 mm Pierse tips. Flat smooth handle with dull finish....
Colibri style 0.1 mm Pierse tips. Flat smooth handle with dull finish....
The Elschnig teeth of this forceps are ideal for grasping sclera during suturing. Delicate tying platform handles the finest suture material. 0.12 mm, 1 x 2 teeth....
Medicine Products:
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, ... today announced it has completed the sale to Galderma ... Dysport owned or held by Valeant for $1.4 billion ... Nestle S.A, which recently completed its acquisition of Galderma. ... divestiture of our products to a company that is ...
(Date:7/10/2014)... July 10, 2014  Decision Resources Group finds ... disease (ID) specialists are willing to prescribe Durata,s ... for use as OPAT, approximately two-thirds of the ... to their hospital inpatients. However, our findings indicate ... are initiated on OPAT following hospital discharge, and ...
(Date:7/10/2014)... -- CVS Caremark Corporation (NYSE: CVS ) today ... dividend of $0.275 (27.5 cents) per share on the corporation,s ... to holders of record on July 21, 2014. ... to helping people on their path to better health as ... States . Through the company,s more than 7,600 CVS/pharmacy ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3